INS and Hyperglycemia: The CGM traces obtained before MDI transition (February 8-20, 2024, while on CSII) revealed repeated postprandial hyperglycemia, supporting our interpretation that executive dysfunction impaired insulin dosing. After switching to MDI on February 21, glycemic control stabilized, and no further DKA occurred.